Dupont Jakob bought BOLT
December 12, 2025 · Form 4 insider transaction
Dupont Jakob bought 1,000 shares of Bolt Biotherapeutics, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,000
Price
N/A
Total value
N/A
InsiderDupont Jakob
RoleDirector
SecurityDirector Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateDecember 12, 2025
Filing dateDecember 16, 2025
Shares owned after1,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reporting person agreed to cancellation of an option granted on May 1, 2025, in exchange for a new option having a lower exercise price.; The option is fully vested and exercisable.